Grzegorz S. Nowakowski

机构：Mayo Clinic, WinnMed, Mayo Clinic in Arizona · ORCID：0000-0002-6955-9393

发表论文 741 篇 · 总被引 14009 次 · h-index 65

代表论文

• Current treatment algorithm: diffuse large B cell lymphoma (2026 · Blood Cancer Journal · 被引 4)
• Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial (2026 · Journal of Clinical Oncology · 被引 2)
• Outcomes from the Multicenter ACCRU-LY-1804/CARiBOU (Cytarabine, Acalabrutinib and Rituximab integrated with Bortezomib-based Outpatient therapy) Trial in 1st line Mantle Cell Lymphoma (2025 · Blood · 被引 1)
• Treatment patterns and outcomes for second-line therapy in large B-cell lymphoma: results from the LEO CReWE study (2026 · Blood Cancer Journal)
• Survival Trends in Waldenström Macroglobulinemia and Comparison of Outcomes with the General US Population (2026 · Research Square)
• Tafasitamab plus lenalidomide and R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma: results from the phase 3 frontMIND study (2026 · Repository@Nottingham (University of Nottingham))